- Received Nasdaq deficiency letter granting a cure period until next annual meeting or October 20, 2027.
- Board appointed independent director Melanie Furlan to Audit Committee on October 27 to resolve non-compliance.
? Neutral AI Sentiment (-1.0 / 10)